(NP (-LRB- -LCB-) (NP-COOD (NP (NN Plasma) (NN cortisol) (NN concentration)) (CC and) (NP (NP (NN blood) (NN leukocyte) (NN content)) (PP (IN of) (NP (NN glucocorticoid) (NNS receptors))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP-COOD (ADJP (JJ deficiency-cold)) (CC vs) (ADJP (JJ deficiency-heat))) (NNS syndromes))))) (-RRB- -RCB-))
(S (NP-SBJ-COOD-10 (NP (NN Plasma) (NN cortisol) (NN concentration)) (CC and) (NP (NP (NN blood) (NN leukocyte) (NN content)) (PP (IN of) (NP (NP (NN glucocorticoid) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NN GCR)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VP-COOD (VP (VBN assayed) (NP (-NONE- *-10)) (PP-11 (IN in) (NP (NP (NP (CD 20) (NNS patients)) (PP (IN with) (NP (NN deficiency) (NNS syndromes)))) (, ,) (NP-COOD (NP (NP (QP (CD 10))) (ADJP (ADJP (JJ cold) (PP (IN in) (NP (NN property)))) (PRN (-LRB- -LRB-) (ADJP (JJ deficiency-cold)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (JJ other) (NP (QP (CD 10)))) (ADJP (ADJP (JJ hot) (PP (IN in) (NP (NN property)))) (PRN (-LRB- -LRB-) (ADJP (JJ deficiency-heat)) (-RRB- -RRB-)))))))) (, ,) (CC and) (RB also) (VP (PP=11 (IN in) (NP (CD 10) (JJ healthy) (NNS individuals))) (PP (IN as) (NP (JJ normal) (NN control))))) (PP (IN for) (NP (NP (DT the) (NN purpose)) (PP (IN of) (S (NP-SBJ (-NONE- *)) (VP (VBG investigating) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (UCP-COOD (ADJP (NN cold)) (CC and) (NP (NN heat))) (NNS syndromes))))))))))) (. .))
(S (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP-SBJ-14 (NP (DT the) (NNS cases)) (PP (IN of) (NP (NP (JJ deficiency-cold) (NN syndrome)) (PRN (-LRB- -LRB-) (NP (NN DCS)) (-RRB- -RRB-))))) (VP (VBD had) (NP-COOD (NP (NP (DT a) (JJ normal) (NN concentration)) (PP (IN of) (NP (NN plasma) (NN cortisol)))) (CC but) (NP (NP (DT a) (JJ lowered) (NN content)) (PP (IN of) (NP (NP (NN GCR)) (PP (IN in) (NP (NNS leukocytes))))))) (SBAR-TMP (WHADVP-13 (WRB when)) (S (NP-SBJ-15 (-NONE- *-14)) (VP (VBN compared) (NP (-NONE- *-15)) (PP (IN with) (NP (NP (DT the) (JJ normal) (NN control)) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN P)) (NP-PRD (QP (JJR less) (IN than) (CD 0.05)))) (-RRB- -RRB-)))) (ADVP (-NONE- *T*-13)))))) (: ;)) (S (NP-SBJ (NP (DT the) (NNS cases)) (PP (IN of) (NP (NP (JJ deficiency-heat) (NN syndrome)) (PRN (-LRB- -LRB-) (NP (NN DHS)) (-RRB- -RRB-))))) (VP (VBD had) (NP (NP-COOD (NP (NP (DT a) (JJR higher) (NN concentration)) (PP (IN of) (NP (NN plasma) (NN cortisol)))) (NP (-NONE- *ICH*-100))) (PP (IN than) (NP (NP (DT the) (JJ normal) (NN control)) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN P)) (NP-PRD (QP (JJR less) (IN than) (CD 0.05)))) (-RRB- -RRB-)))) (CC and) (NP-100 (NP (DT a) (ADJP (RB slightly) (JJR higher)) (NN content)) (PP (IN of) (NP (NN GCR))) (PP (IN in) (NP (NNS leukocytes)))))) (. .)))
(S (NP-SBJ (PRP It)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S-COOD (S (NP-SBJ-17 (DT the) (NN DCS)) (VP (VBZ is) (VP (VBN characterized) (NP (-NONE- *-17)) (PP-18 (IN by) (NP-LGS (NP (VBN diminished) (JJ biological) (NNS effects)) (PP (IN of) (NP (JJ adrenocortical) (NN activity)))))))) (, ,) (IN while) (S (NP-SBJ=17 (DT the) (NN DHS)) (, ,) (PP=18 (IN by) (NP-LGS (NP (JJ augmented) (JJ biological) (NNS effects)) (PP (IN of) (NP (JJ adrenocortical) (NN activity)))))))))) (. .))
